Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Advanced Age Is Not a Barrier to Total Knee Arthroplasty: A Detailed Analysis of Outcomes and Complications in an Elderly Cohort Compared With Average Age Total Knee Arthroplasty Patients.

Klasan A, Putnis SE, Yeo WW, Fritsch BA, Coolican MR, Parker DA.

J Arthroplasty. 2019 May 9. pii: S0883-5403(19)30463-2. doi: 10.1016/j.arth.2019.05.007. [Epub ahead of print]

PMID:
31155457
2.

Evaluating the Effect of a Web-Based E-Learning Tool for Health Professional Education on Clinical Vancomycin Use: Comparative Study.

Bond SE, Crowther SP, Adhikari S, Chubaty AJ, Yu P, Borchard JP, Boutlis CS, Yeo WW, Miyakis S.

JMIR Med Educ. 2018 Feb 26;4(1):e5. doi: 10.2196/mededu.7719.

3.

Impact of an antimicrobial stewardship intervention on appropriateness of prescribing for community-acquired pneumonia in an Australian regional hospital.

Bond SE, Boutlis CS, Yeo WW, Miyakis S.

Intern Med J. 2017 May;47(5):582-585. doi: 10.1111/imj.13401.

PMID:
28503879
4.

Adult muscle-derived stem cells engraft and differentiate into insulin-expressing cells in pancreatic islets of diabetic mice.

Mitutsova V, Yeo WWY, Davaze R, Franckhauser C, Hani EH, Abdullah S, Mollard P, Schaeffer M, Fernandez A, Lamb NJC.

Stem Cell Res Ther. 2017 Apr 18;8(1):86. doi: 10.1186/s13287-017-0539-9.

5.

Design and Implementation of a Novel Web-Based E-Learning Tool for Education of Health Professionals on the Antibiotic Vancomycin.

Bond SE, Crowther SP, Adhikari S, Chubaty AJ, Yu P, Borchard JP, Boutlis CS, Yeo WW, Miyakis S.

J Med Internet Res. 2017 Mar 30;19(3):e93. doi: 10.2196/jmir.6971.

6.

Outcomes of multisite antimicrobial stewardship programme implementation with a shared clinical decision support system.

Bond SE, Chubaty AJ, Adhikari S, Miyakis S, Boutlis CS, Yeo WW, Batterham MJ, Dickson C, McMullan BJ, Mostaghim M, Li-Yan Hui S, Clezy KR, Konecny P.

J Antimicrob Chemother. 2017 Jul 1;72(7):2110-2118. doi: 10.1093/jac/dkx080.

PMID:
28333302
7.

The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.

Bond SE, Boutlis CS, Yeo WW, Pratt WAB, Orr ME, Miyakis S.

J Hosp Infect. 2017 Apr;95(4):387-393. doi: 10.1016/j.jhin.2016.12.009. Epub 2016 Dec 18.

PMID:
28131640
8.

Use of romiplostim in patients with chronic idiopathic thrombocytopenic purpura during perioperative period.

Ramakrishna R, Rehman A, Ramakrishna S, Alexander W, Yeo WW.

Intern Med J. 2015 Jul;45(7):718-24. doi: 10.1111/imj.12794.

PMID:
25904300
9.

Safety profile of dextran-spermine gene delivery vector in mouse lungs.

Yeo WW, Hosseinkhani H, Rahman SA, Rosli R, Domb AJ, Abdullah S.

J Nanosci Nanotechnol. 2014 May;14(5):3328-36.

PMID:
24734548
10.

How can we improve junior doctor prescribing?

Gaetani L, Yeo WW.

Intern Med J. 2012 Sep;42(9):1050-2. doi: 10.1111/j.1445-5994.2012.02882.x.

PMID:
24020344
11.

A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).

Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS.

Age Ageing. 2007 Mar;36(2):151-6. Epub 2006 Dec 15.

PMID:
17175564
12.

The effect of chronic tobacco smoking on arterial stiffness.

Rehill N, Beck CR, Yeo KR, Yeo WW.

Br J Clin Pharmacol. 2006 Jun;61(6):767-73.

13.

Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.

Kay LJ, Yeo WW, Peachell PT.

Br J Pharmacol. 2006 Apr;147(7):707-13.

14.

A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation.

Channer KS, Birchall A, Steeds RP, Walters SJ, Yeo WW, West JN, Muthusamy R, Rhoden WE, Saeed BT, Batin P, Brooksby WP, Wilson I, Grant S.

Eur Heart J. 2004 Jan;25(2):144-50.

PMID:
14720531
15.

Coronary risk versus cardiovascular risk for treatment decisions in mild hypertension.

Yeo WW, Yeo KR.

J Cardiovasc Risk. 2002 Oct;9(5):275-80.

PMID:
12394321
16.

Should we treat high-normal blood pressure?

Yeo KR, Yeo WW.

J Hypertens. 2002 Oct;20(10):2057-62.

PMID:
12359985
18.

Predicting CHD risk in patients with diabetes mellitus.

Yeo WW, Yeo KR.

Diabet Med. 2001 May;18(5):341-4. No abstract available.

PMID:
11472442
19.
20.

Sonographic findings in masseter-muscle metastases.

Ahuja AT, King AD, Bradley MJ, Yeo WW, Mok TS, Metreweli C.

J Clin Ultrasound. 2000 Jul-Aug;28(6):299-302.

PMID:
10867669
21.

Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.

Wallis EJ, Ramsay LE, Ul Haq I, Ghahramani P, Jackson PR, Rowland-Yeo K, Yeo WW.

BMJ. 2000 Mar 11;320(7236):671-6. Erratum in: BMJ 2000 Apr 15;320(7241):1034.

22.

Implication of recent trials with b-hydroxy-b-methylglutaryl coenzyme A reductase inhibitors for hypertension management.

Haq IU, Wallis EJ, Jackson PR, Yeo WW, Ramsay LE.

J Hypertens. 1999 Nov;17(11):1641-6.

PMID:
10608479
23.

Enhanced cholesterol reduction by simvastatin in diltiazem-treated patients.

Yeo KR, Yeo WW, Wallis EJ, Ramsay LE.

Br J Clin Pharmacol. 1999 Oct;48(4):610-5.

24.

Association of panic disorder and panic attacks with hypertension.

Davies SJ, Ghahramani P, Jackson PR, Noble TW, Hardy PG, Hippisley-Cox J, Yeo WW, Ramsay LE.

Am J Med. 1999 Oct;107(4):310-6.

PMID:
10527031
25.
27.

Cholesterol screening and management guidelines. Policy based on Sheffield table fully satisfies authors' criteria.

Ramsay LE, Wallis EJ, Haq IU, Jackson PR, Yeo WW.

BMJ. 1999 Apr 24;318(7191):1140-1. No abstract available.

PMID:
10366266
28.

Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Haq IU, Wallis EJ, Yeo WW, Jackson PR, Ramsay LE.

JAMA. 1999 Feb 3;281(5):414; author reply 417-9. No abstract available.

PMID:
9952191
29.

Cholestanol and survival with simvastatin. More data are needed.

Wallis EJ, Williamson R, Ramsay LE, Yeo WW, Jackson PR.

BMJ. 1998 Oct 31;317(7167):1252-3. No abstract available.

30.

Statins for prevention of stroke.

Wallis EJ, Ramsay LE, Yeo WW, Jackson PR.

Lancet. 1998 Sep 12;352(9131):909-10. No abstract available.

PMID:
9743018
31.

Use of statins. Sheffield table is useful.

Ramsay LE, Wallis EJ, Haq IU, Williamson R, Yeo WW, Jackson PR.

BMJ. 1998 Aug 15;317(7156):473-4. No abstract available.

32.

The rationale for differing national recommendations for the treatment of hypertension.

Ramsay LE, Wallis EJ, Yeo WW, Jackson PR.

Am J Hypertens. 1998 Jun;11(6 Pt 2):79S-88S; discussion 95S-100S. Review.

PMID:
9655567
33.

Protein binding of aspirin and salicylate measured by in vivo ultrafiltration.

Ghahramani P, Rowland-Yeo K, Yeo WW, Jackson PR, Ramsay LE.

Clin Pharmacol Ther. 1998 Mar;63(3):285-95.

PMID:
9542472
34.

Drug therapy for coronary heart disease: the Sheffield table.

Ramsay LE, Wallis EJ, Haq IU, Yeo WW, Jackson PR.

Lancet. 1998 Feb 7;351(9100):443-4. No abstract available.

PMID:
9482325
35.

Gastric outflow obstruction caused by gall stones and leading to death by complex metabolic derangement.

Wight CO, Seed M, Yeo WW, McCulloch TA.

J Clin Pathol. 1997 Nov;50(11):963-5.

36.

Use of statins. Evidence on effectiveness is stronger for statins than for other treatments.

Wallis EJ, Ramsay LE, Yeo WW, Jackson PR, Pickin M, Haq IU.

BMJ. 1997 Dec 13;315(7122):1618-9. No abstract available.

37.

Drug therapy for coronary heart disease: the Sheffield table.

Wallis EJ, Ramsay LE, Jackson PR, Yeo WW, Williamson R.

Lancet. 1997 Dec 20-27;350(9094):1852. No abstract available.

PMID:
9428275
38.

Panic disorder, anxiety and depression in resistant hypertension--a case-control study.

Davies SJ, Ghahramani P, Jackson PR, Hippisley-Cox J, Yeo WW, Ramsay LE.

J Hypertens. 1997 Oct;15(10):1077-82.

PMID:
9350581
39.

Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes.

Chadwick IG, O'Toole L, Morice AH, Yeo WW, Jackson PR, Ramsay LE.

J Cardiovasc Pharmacol. 1997 Apr;29(4):485-9.

PMID:
9156358
40.

Cholesterol and prevention of coronary heart disease.

Haq IU, Jackson PR, Yeo WW, Ramsay LE.

Lancet. 1997 Jan 18;349(9046):210-1. No abstract available.

PMID:
9111570
41.

Cross-over trials--a commentary.

Jackson PR, Yeo WW.

Eur J Clin Pharmacol. 1997;52(2):155-8. No abstract available.

PMID:
9174686
42.

Interpretation of prospective trials in hypertension: do treatment guidelines accurately reflect current evidence?

Ramsay LE, ul Haq I, Yeo WW, Jackson PR.

J Hypertens Suppl. 1996 Dec;14(5):S187-94. Review.

PMID:
9120677
43.

The Sheffield table for primary prevention of coronary heart disease: corrected.

Ramsay LE, Haq IU, Jackson PR, Yeo WW.

Lancet. 1996 Nov 2;348(9036):1251. No abstract available.

PMID:
8898071
44.

No relation between angiotensin-converting enzyme gene polymorphism and dermal response to bradykinin in healthy subjects.

Chadwick IG, Kraskiewicz M, Yeo WW, Higgins KS, Jackson PR, Ramsay LE.

Clin Sci (Lond). 1996 Nov;91(5):617-20.

PMID:
8964127
45.

Lipid-lowering for prevention of coronary heart disease: what policy now?

Ul Haq I, Ramsay LE, Pickin DM, Yeo WW, Jackson PR, Payne JN.

Clin Sci (Lond). 1996 Oct;91(4):399-413. Erratum in: Clin Sci (Colch) 1996 Dec;91(6):773-4.

PMID:
8983865
46.

Cross over trials.

Jackson PR, Yeo WW.

Br J Clin Pharmacol. 1996 Sep;42(3):401-3. No abstract available.

47.

Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table.

Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, Payne JN.

Lancet. 1996 Aug 10;348(9024):387-8. No abstract available. Erratum in: Lancet. 1996 Nov 2;348(9036):1251.

PMID:
8709740
48.

Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease.

Haq IU, Jackson PR, Yeo WW, Ramsay LE.

Lancet. 1995 Dec 2;346(8988):1467-71.

PMID:
7490996
49.

Resolution of ACE inhibitor cough: changes in subjective cough and responses to inhaled capsaicin, intradermal bradykinin and substance-P.

Yeo WW, Chadwick IG, Kraskiewicz M, Jackson PR, Ramsay LE.

Br J Clin Pharmacol. 1995 Nov;40(5):423-9.

50.

The effects of dietary change on serum cholesterol.

Haq IU, Yeo WW, Jackson PR, Ramsay LE.

Proc Nutr Soc. 1995 Nov;54(3):601-16. Review. No abstract available.

PMID:
8643699

Supplemental Content

Support Center